Valuation Roche Holding AG

Equities

Real-time Estimate Cboe Europe Other stock markets 09:20:11 16/03/2026 GMT			5-day change	1st Jan Change
319.15 ^CHF	-0.48%		-3.79%	-2.56%

06:05am	Roche receives CE Mark for first IVD immunoassay blood test to identify carriers of ApoE4	RE
03-12	ROCHE HOLDINGS AG : Deutsche Bank reaffirms its Neutral rating	ZD

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	306,810	239,812	197,073	205,191	262,098	256,083	-	-
Change	-	-21.84%	-17.82%	4.12%	27.73%	-2.3%	-	-
Enterprise Value (EV) ¹	324,977	255,396	215,772	222,528	278,258	264,897	258,068	251,220
Change	-	-21.41%	-15.51%	3.13%	25.04%	-4.8%	-2.58%	-2.65%
P/E ratio	23.4x	18.9x	17.1x	24.8x	20.5x	17.3x	16.1x	14.9x
PBR	13.2x	8.29x	5.91x	5.67x	7.8x	6.15x	5.12x	4.33x
PEG	-	-3.69x	-2.48x	-0.9x	0.4x	1.1x	2.04x	1.92x
Capitalization / Revenue	4.89x	3.79x	3.36x	3.39x	4.26x	4.08x	3.94x	3.79x
EV / Revenue	5.17x	4.04x	3.67x	3.68x	4.52x	4.22x	3.97x	3.72x
EV / EBITDA	13.2x	10.2x	9.82x	9.45x	11.3x	10.4x	9.6x	8.8x
EV / EBIT	14.8x	11.5x	11.2x	10.7x	12.7x	11.8x	10.9x	10x
EV / FCF	20.7x	19.6x	19.1x	14.5x	23.6x	17x	15.2x	13.5x
FCF Yield	4.83%	5.11%	5.23%	6.89%	4.24%	5.87%	6.56%	7.43%
Dividend per Share ²	9.3	9.5	9.6	9.7	9.8	10.05	10.32	10.58
Rate of return	2.45%	3.27%	3.93%	3.8%	2.99%	3.13%	3.22%	3.3%
EPS ²	16.2	15.37	14.31	10.31	16.04	18.51	19.98	21.53
Distribution rate	57.4%	61.8%	67.1%	94.1%	61.1%	54.3%	51.7%	49.1%
Net sales ¹	62,801	63,281	58,716	60,495	61,516	62,771	64,963	67,590
EBITDA ¹	24,692	25,015	21,976	23,538	24,608	25,388	26,885	28,533
EBIT ¹	21,897	22,173	19,240	20,823	21,833	22,407	23,752	25,115
Net income ¹	13,930	12,421	11,498	8,277	12,880	14,565	15,609	17,321
Net Debt ¹	18,167	15,584	18,699	17,337	16,160	8,814	1,985	-4,862
Reference price ²	379.10	290.50	244.50	255.50	328.20	320.70	320.70	320.70
Nbr of stocks (in thousands)	800,952	800,579	798,652	796,789	796,317	795,618	-	-
Announcement Date	03/02/22	02/02/23	01/02/24	30/01/25	29/01/26	-	-	-

¹CHF in Million²CHF

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ROCHE HOLDING AG	17.32x	4.22x	10.43x	3.13%	324B
ELI LILLY AND COMPANY	28.95x	10.91x	21.91x	0.67%	880B
JOHNSON & JOHNSON	25.63x	5.96x	16.23x	2.19%	582B
ABBVIE INC.	24x	6.55x	13.15x	3.16%	388B
ASTRAZENECA PLC	23.94x	4.98x	13.83x	1.75%	295B
NOVARTIS AG	20.93x	5.64x	13.96x	2.87%	293B
MERCK & CO., INC.	27.02x	4.74x	14.82x	2.92%	286B
AMGEN INC.	24.64x	6.26x	11.14x	2.74%	197B
GILEAD SCIENCES, INC.	20.1x	6.12x	11.06x	2.25%	180B
NOVO NORDISK A/S	11.62x	4.21x	8.75x	4.33%	168B
Average	22.41x	5.96x	13.53x	2.6%	359.42B
Weighted average by Cap.	24.12x	6.82x	15.38x	2.22%